A. Fleming

1.2k total citations · 1 hit paper
10 papers, 813 citations indexed

About

A. Fleming is a scholar working on Molecular Biology, Surgery and Pharmacology. According to data from OpenAlex, A. Fleming has authored 10 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Pharmacology. Recurrent topics in A. Fleming's work include Microbial Natural Products and Biosynthesis (2 papers), Historical Medical Research and Treatments (1 paper) and Cardiac, Anesthesia and Surgical Outcomes (1 paper). A. Fleming is often cited by papers focused on Microbial Natural Products and Biosynthesis (2 papers), Historical Medical Research and Treatments (1 paper) and Cardiac, Anesthesia and Surgical Outcomes (1 paper). A. Fleming collaborates with scholars based in United States, Hungary and Canada. A. Fleming's co-authors include Kálmán Tory, Enikő Kulcsár, Eva Péterfai, László Korányi, Botond Literáti-Nagy, J. Mandl, Attila Kolonics, Paul L. Appel, K. A. Bettelheim and G. T. Banks and has published in prestigious journals such as Circulation, Clinical Infectious Diseases and Brain Research Bulletin.

In The Last Decade

A. Fleming

9 papers receiving 781 citations

Hit Papers

On the Antibacterial Action of Cultures of a Penicillium,... 1980 2026 1995 2010 1980 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Fleming United States 9 319 156 118 75 71 10 813
L. J. Filippich Australia 18 132 0.4× 122 0.8× 108 0.9× 55 0.7× 90 1.3× 64 921
L Lindqvist Sweden 17 231 0.7× 87 0.6× 117 1.0× 110 1.5× 17 0.2× 36 717
J. Van Eldere Belgium 19 569 1.8× 176 1.1× 106 0.9× 200 2.7× 39 0.5× 32 1.2k
J. W. Lightbown United Kingdom 11 258 0.8× 153 1.0× 87 0.7× 86 1.1× 31 0.4× 50 586
G. D. KORITZ United States 18 138 0.4× 350 2.2× 39 0.3× 37 0.5× 82 1.2× 62 1.1k
Roy Cleeland United States 21 420 1.3× 307 2.0× 249 2.1× 159 2.1× 86 1.2× 66 1.2k
J.‐L. Riond Switzerland 15 117 0.4× 345 2.2× 143 1.2× 44 0.6× 61 0.9× 37 849
Sachiko Gotô Japan 20 411 1.3× 346 2.2× 247 2.1× 162 2.2× 87 1.2× 92 1.1k
Rosario Musumeci Italy 20 294 0.9× 190 1.2× 129 1.1× 120 1.6× 64 0.9× 51 1.1k
William M. O’Leary United States 17 393 1.2× 53 0.3× 40 0.3× 59 0.8× 212 3.0× 43 1.2k

Countries citing papers authored by A. Fleming

Since Specialization
Citations

This map shows the geographic impact of A. Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Fleming more than expected).

Fields of papers citing papers by A. Fleming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Fleming. The network helps show where A. Fleming may publish in the future.

Co-authorship network of co-authors of A. Fleming

This figure shows the co-authorship network connecting the top 25 collaborators of A. Fleming. A scholar is included among the top collaborators of A. Fleming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Fleming. A. Fleming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Jiménez, Ana Gabriela, et al.. (2019). Does Cellular Metabolism from Primary Fibroblasts and Oxidative Stress in Blood Differ between Mammals and Birds? The (Lack-thereof) Scaling of Oxidative Stress. Integrative and Comparative Biology. 59(4). 953–969. 30 indexed citations
2.
Literáti-Nagy, Botond, Eva Péterfai, Enikő Kulcsár, et al.. (2010). Beneficial effect of the insulin sensitizer (HSP inducer) BGP-15 on olanzapine-induced metabolic disorders. Brain Research Bulletin. 83(6). 340–344. 27 indexed citations
3.
Literáti-Nagy, Botond, Enikő Kulcsár, Eva Péterfai, et al.. (2009). Improvement of Insulin Sensitivity by a Novel Drug, BGP-15, in Insulin-resistant Patients: A Proof of Concept Randomized Double-blind Clinical Trial. Hormone and Metabolic Research. 41(5). 374–380. 93 indexed citations
4.
Fleming, A.. (2001). On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. 1929.. PubMed. 79(8). 780–90. 187 indexed citations
5.
Bishop, Mike, Joseph Jorgens, W. C. Shoemaker, et al.. (1991). The relationship between ARDS, pulmonary infiltration, fluid balance, and hemodynamics in critically ill surgical patients.. PubMed. 57(12). 785–92. 21 indexed citations
6.
Kram, Harry B., R. A. White, J Tabrisky, et al.. (1985). Transcutaneous oxygen recovery and toe pulse reappearance time in the assessment of peripheral vascular disease.. Circulation. 72(5). 1022–1027. 19 indexed citations
7.
Fleming, A.. (1980). On the Antibacterial Action of Cultures of a Penicillium, with Special Reference to Their Use in the Isolation of B. influenzae. Clinical Infectious Diseases. 2(1). 129–139. 392 indexed citations breakdown →
8.
Bascomb, S, et al.. (1975). The Properties and Large-scale Production of L-Asparaginase from Citrobacter. Journal of General Microbiology. 91(1). 1–16. 24 indexed citations
9.
Fleming, G. W. T. H., E. D. Adrian, Cormac McCarthy, et al.. (1951). BJZ volume 97 issue 406 Cover and Front matter. Journal of Mental Science. 97(406). f1–f12. 1 indexed citations
10.
Fleming, A., et al.. (1951). Syringe Needles and Mass Inoculation Technique. BMJ. 1(4706). 543–546. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026